This article summarized the latest R&D progress of Dextromethorphan polistirex, the Mechanism of Action for Dextromethorphan polistirex, and the drug target R&D trends for Dextromethorphan polistirex.

As a functionally diversified transcription factor, STAT3 can interact with a large number of signal molecules and forms various intra- and extracellular signal pathways.

This article summarized the latest R&D progress of Deucravacitinib, the Mechanism of Action for Deucravacitinib, and the drug target R&D trends for Deucravacitinib.

Remegen's Novel Medication Telitacicept (RC18) Achieves Favorable Phase III Outcomes, Applied for a Secondary Use in Managing Rheumatoid Arthritis.

Me-too drugs specifically refer to drugs with their own intellectual property rights, whose efficacy is comparable to that of innovative breakthrough drugs.

This article summarized the latest R&D progress of Deutetrabenazine, the Mechanism of Action for Deutetrabenazine, and the drug target R&D trends for Deutetrabenazine.

Mesentech recently revealed that its Phase 1 trial has begun, and the initial patients have already received their doses of MES1022.

This article summarized the latest R&D progress of Deoxycholic acid, the Mechanism of Action for Deoxycholic acid, and the drug target R&D trends for Deoxycholic acid.

Elpiscience Biopharmaceuticals has revealed that the initial patient has received a dose in a Phase 1 clinical study of the anti-LILRB2 monoclonal antibody ES009 in Australia.

Me-better class of innovative drugs refers to new drugs that have clinical efficacy or safety superior to that of the original innovative drug.

This article summarized the latest R&D progress of Decitabine, the Mechanism of Action for Decitabine, and the drug target R&D trends for Decitabine.

FIC stands for First in Class, which refers to pioneering drugs.